A chimeric TCR-beta chain confers increased susceptibility to EAE.

Area of Science:

• Immunology
• Neuroscience
• Autoimmunity

Background:

• Autoreactive T cells, specifically myelin-specific CD4(+) T cells, are implicated in central nervous system (CNS) demyelination in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE).
• Understanding T cell receptor (TCR) signaling mechanisms is crucial for developing strategies against T cell activation in autoimmune diseases.

Purpose of the Study:

• To investigate the impact of a chimeric TCR-beta chain (betaIII) with enhanced antigen sensitivity on T cell activation and autoimmune responses in a mouse model.
• To determine if the modified TCR affects T helper cell differentiation and susceptibility to EAE.

Main Methods:

• Generation of MOG(35-55) specific TCR transgenic mice expressing either wild-type or chimeric betaIII TCR-beta chains.
• In vitro proliferation assays of T cells in response to MOG(35-55) antigen.
• Assessment of Fas-mediated cell death and susceptibility to EAE.

Main Results:

• Naïve and TH1-skewed T cells expressing the chimeric betaIII chain exhibited increased proliferation compared to wild-type cells, particularly at low antigen concentrations.
• No significant difference in proliferation was observed between wild-type and betaIII T cells when skewed towards a TH2 phenotype.
• Blocking Fas-mediated cell death did not differentially affect wild-type and betaIII TH1 T cells, indicating intact Fas-FasL signaling in betaIII cells.
• Mice expressing the chimeric betaIII TCR showed increased susceptibility to EAE compared to wild-type TCR transgenic mice.

Conclusions:

• The modification of the TCR-beta chain's transmembrane domain influences TH1 T cell responses and susceptibility to EAE, but not TH2 cell responses.
• These findings highlight the role of TCR signaling in autoimmune T cell activation and provide potential targets for therapeutic intervention in MS.